1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory MalignanciesNeoplasms by Site, central nervous system cancer, central nervous system neoplasm, neoplasm, nervous system disorderRecruitingPhase 1 / Phase 22024-02-07NCT03838042